Successful engraftment of allogeneic CD34-enriched marrow cell transplantation from HLA-mismatched parental donors

Bone Marrow Transplantation

Volumn 17, Issue 6, 1996, Pages 985-991

  Yabe, H ^a   Yabe, M ^a   Hattori, K ^a   Hinohara, T ^a   Morimoto, T ^a   Nakamura, Y ^b   Noma, M ^b   Takei, M ^b   Kobayashi, N ^b   Tsuji, K ^b   Kato, S ^a  

^a TOKAI UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Allogeneic BMT; CD34+ cells; Engraftment; Graft versus host disease; Mismatched donor

Indexed keywords

CD34 ANTIGEN; CD5 ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CASE REPORT; CELL SELECTION; CHIMERA; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HEMATOPOIESIS; HISTOCOMPATIBILITY; HLA SYSTEM; HUMAN; PARENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETICULOCYTE COUNT; THROMBOCYTE COUNT;

ADULT; ANIMALS; ANTIGENS, CD34; BONE MARROW CELLS; CELL TRANSPLANTATION; CELLS, CULTURED; CHILD; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; MALE; MICE; SHEEP; TRANSPLANTATION, HOMOLOGOUS;

EID: 8944259892     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Prentice HG, Blacklock HA, Janossy G, Bradstock KF, Skeggs D, Goldstein G. Use of anti-T-cell monoclonal antibody OKT-3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukemia. Lancet 1982; 1: 700-703.
2. Reisner Y, Kapoor N, Kirkpatrick D et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean aggulutinin and sheep red blood cells. Blood 1983; 61: 341-348.
3. Antin JH, Bierer BE, Smith BR et al. Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematological malignancies. Blood 1991; 78: 2139-2149.
4. Ash RC, Casper JT, Christopher R et al. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. New Engl J Med 1990; 322: 485-494.
5. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantation from unrelated donors facilitated by the national marrow donor program. New Engl J Med 1993; 328: 593-602.
6. + marrow cells engraft lethally irradiated baboons. J Clin Invest 1988; 81: 951-955.
7. + marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717-1722.
8. + peripheral blood stem cells using immunomagnetic positive selection system and a nylon-wool column: prior monocyte depletion using a nylon-wool column. J Hematother 1994; 3: 129-133.
9. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipient of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
10. Civin CI, Strauss LC, Broval C et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG1a cells. J Immunol 1984; 133: 157-165.
11. Martin PJ, Hansen JA, Buckner CD et al. Effect of in vitro depletion of T cells in HLA-identical allogeneic marrow graft. Blood 1985; 66: 664-672.
12. Kernan NA, Bordignon C, Heller G et al. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood 1989; 74: 2227-2236.
13. Ema H, Suda T, Miura Y, Nakauchi H. Colony formation of clone-sorted human hematopoietic progenitors. Blood 1990; 75: 1941-1946.
14. Avraham H, Vannier E, Cowley S et al. Effect of stem factor, c-kit ligand on human megakaryocytic cells. Blood 1992; 79: 365-371.
15. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T-cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
16. Kernan NA, Collins NH, Juliano L et al. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-versus-host disease. Blood 1986; 68: 770-773.
17. Drobyski WR, Keever CA, Roth MS et al. Salvage therapy using donor leukocyte infusions as treatment for relapsed chronic leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood 1993; 82: 2310-2318.
18. Papadopoulos EB, Ladanyi M, Emanuel D et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New Engl J Med 1994; 330: 1185-1191.
19. Johnson BD, Drobyski WR, Truitt RL. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant 1993; 11: 329-336.